A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Pharmaceutical Companies Join Forces to Find COVID-19 Treatment


Three pharmaceutical companies have partnered in clinical trials to test drugs from each manufacturer to see whether they may help patients with COVID-19. AbbVie Inc, Amgen Inc, and Takeda are part of a broader coalition—COVID Research & Development Alliance—that also includes the Quantum Leap Healthcare Collaborative and United States Food and Drug Administration. The partnership is testing a human immunodeficiency virus drug from AbbVie, a psoriasis medication from Amgen, and an injection used to address hereditary angioedema by Takeda. The hope is that these agents may address the overactive inflammatory response caused by COVID-19. Results of the trials may be available within 6 weeks. Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy